I agree that this site is using cookies. You can find further informations here.
X
Johns, Jeffrey
256  results:
OpenAccess-fulltext X
Search for persons X
?
1

Dietary sources of melatonin and benefits from production o..:

Sangsopha, Jintana ; Johns, Nutjaree Pratheepawanit ; Johns, Jeffrey.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230083/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
2

Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Anal..:

Salek, Sam M ; Lussier Hoskyn, Sarah ; Johns, Jeffrey..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387957/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
3

Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Anal..:

Salek, Mir-Saeed Shayegan ; Hoskyn, Sarah Lussier ; Johns, Jeffrey..
Frontiers in Pharmacology.  , 2019
Link: http://hdl.handle.net/22..
 
?
4

Factors influencing delays in patient access to new medicin..:

Salek, Mir-Saeed Shayegan ; Hoskyn, Sarah Lussier ; Johns, Jeffrey..
Frontiers in Pharmacology.  , 2019
Link: http://hdl.handle.net/22..
 
?
5

Appraisal of patient-reported outcome measures in analogous..:

Salek, Mir-Saeed Shayegan ; Ionova, Tatyana ; Johns, Jeffrey.
Quality of Life Research.  , 2018
Link: http://hdl.handle.net/22..
 
?
6

Exploring Adversarial Examples in Malware Detection:

Suciu, Octavian ; Coull, Scott E ; Johns, Jeffrey
http://arxiv.org/abs/1810.08280.  , 2018
Link: http://arxiv.org/abs/181..
 
?
7

Determination of melatonin content in traditional Thai herb..:

Padumanonda, Tanit ; Johns, Jeffrey ; Sangkasat, Autcharaporn.
http://www.darujps.com/content/22/1/6.  , 2014
Link: http://www.darujps.com/c..
 
?
8

Basis Construction and Utilization for Markov Decision Proc..:

Johns, Jeffrey Thomas
https://scholarworks.umass.edu/open_access_dissertations/177.  , 2010
Link: https://scholarworks.uma..
 
?
9

Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Anal..:

Sam M. Salek ; Sarah Lussier Hoskyn ; Jeffrey Johns..
https://www.frontiersin.org/article/10.3389/fphar.2018.01578/full.  , 2019
Link: https://doi.org/10.3389/..
 
?
10

Image_2_Pan-Canadian Pharmaceutical Alliance (pCPA): Timeli..:

Sam M. Salek ; Sarah Lussier Hoskyn ; Jeffrey Johns..
doi:10.3389/fphar.2018.01578.s002.  , 2019
Link: https://doi.org/10.3389/..
 
?
11

Image_3_Pan-Canadian Pharmaceutical Alliance (pCPA): Timeli..:

Sam M. Salek ; Sarah Lussier Hoskyn ; Jeffrey Johns..
doi:10.3389/fphar.2018.01578.s003.  , 2019
Link: https://doi.org/10.3389/..
 
?
12

Image_1_Pan-Canadian Pharmaceutical Alliance (pCPA): Timeli..:

Sam M. Salek ; Sarah Lussier Hoskyn ; Jeffrey Johns..
doi:10.3389/fphar.2018.01578.s001.  , 2019
Link: https://doi.org/10.3389/..
 
?
13

Image_1_Factors Influencing Delays in Patient Access to New..:

Sam Salek ; Sarah Lussier Hoskyn ; Jeffrey Roy Johns..
doi:10.3389/fphar.2019.00196.s001.  , 2019
Link: https://doi.org/10.3389/..
 
?
14

Image_2_Factors Influencing Delays in Patient Access to New..:

Sam Salek ; Sarah Lussier Hoskyn ; Jeffrey Roy Johns..
doi:10.3389/fphar.2019.00196.s002.  , 2019
Link: https://doi.org/10.3389/..
 
?
15

Factors Influencing Delays in Patient Access to New Medicin..:

Sam Salek ; Sarah Lussier Hoskyn ; Jeffrey Roy Johns..
https://www.frontiersin.org/article/10.3389/fphar.2019.00196/full.  , 2019
Link: https://doi.org/10.3389/..
 
1-15